These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7385465)

  • 1. Urodynamic response of unstable bladder to flavoxate.
    Zanollo A; Catanzaro F
    Urol Int; 1980; 35(3):176-81. PubMed ID: 7385465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
    Hermieu JF;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between the combination emepronium bromide/flavoxate and emepronium bromide in the treatment of detrusor instability.
    Aagaard J; Reuther K; Stimpel H
    Urol Int; 1983; 38(3):191-2. PubMed ID: 6868218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability.
    Cardozo LD; Stanton SL
    J Urol; 1979 Jul; 122(1):58-9. PubMed ID: 458990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flavoxate on hyperactive detrusor muscle.
    Jonas U; Petri E; Kissel J
    Eur Urol; 1979; 5(2):106-9. PubMed ID: 421699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of detrusor hyperreflexia in multiple sclerosis: a double-blind, crossover clinical trial comparing methantheline bromide (Banthine), flavoxate chloride (Urispas) and meladrazine tartrate (Lisidonil).
    Hebjorn S
    Urol Int; 1977; 32(2-3):209-17. PubMed ID: 20683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavoxate hydrochloride in the treatment of detrusor instability.
    Delaere KP; Michiels HG; Debruyne FM; Moonen WA
    Urol Int; 1977; 32(5):377-81. PubMed ID: 610033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of urgency and urge incontinence with flavoxate in the People's Republic of China.
    Gu FL; Reng ZY; Shang GZ; Shao HX; Wang B; Cheng ZD; Jiang Y; Zhao WP; Zheng JF; Qu CT
    J Int Med Res; 1987; 15(5):312-8. PubMed ID: 3315777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability.
    Chapple CR; Parkhouse H; Gardener C; Milroy EJ
    Br J Urol; 1990 Nov; 66(5):491-4. PubMed ID: 2249117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women.
    Robinson JM; Brocklehurst JC
    Br J Urol; 1983 Aug; 55(4):371-6. PubMed ID: 6349743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavoxate hydrochloride for urinary urgency after pelvic radiotherapy: comparison of 600 mg versus 1200 mg daily dosages.
    Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
    J Int Med Res; 1988; 16(1):71-4. PubMed ID: 3350206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urodynamic studies on detrusor hyperreflexia. III. Clinical treatment of detrusor hyperreflexia by TURP, oral administration of flavoxate and prolonged bladder distension (author's transl)].
    Furuya S; Yokoyama E; Kumamoto Y; Tsukamoto T
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1597-604. PubMed ID: 7345197
    [No Abstract]   [Full Text] [Related]  

  • 13. Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients.
    Ockrim J; Laniado ME; Khoubehi B; Renzetti R; Finazzi Agrò E; Carter SS; Tubaro A
    BJU Int; 2005 Mar; 95(4):587-90. PubMed ID: 15705085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.
    Nitti VW; Kim Y; Combs AJ
    J Urol; 1997 Feb; 157(2):600-3. PubMed ID: 8996367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urethrocystometric findings in urgency.
    Obrink A; Bunne G
    Urol Int; 1978; 33(6):377-80. PubMed ID: 570752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?
    Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):123-8. PubMed ID: 16823541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
    Sehgal R; Paul P; Mohanty NK
    J Trop Pediatr; 2007 Aug; 53(4):259-63. PubMed ID: 17496326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.
    Grüneberger A
    Br J Obstet Gynaecol; 1984 Mar; 91(3):275-8. PubMed ID: 6367811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence.
    Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
    J Int Med Res; 1988; 16(3):244-8. PubMed ID: 3044876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly.
    Briggs RS; Castleden CM; Asher MJ
    J Urol; 1980 May; 123(5):665-6. PubMed ID: 7420551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.